1. Home
  2. PDFS vs ELVN Comparison

PDFS vs ELVN Comparison

Compare PDFS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$30.19

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$16.82

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
ELVN
Founded
1992
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PDFS
ELVN
Price
$30.19
$16.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$34.50
$41.20
AVG Volume (30 Days)
303.9K
661.3K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$206,706,000.00
N/A
Revenue This Year
$24.45
N/A
Revenue Next Year
$18.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.23
N/A
52 Week Low
$15.91
$13.30
52 Week High
$32.31
$25.37

Technical Indicators

Market Signals
Indicator
PDFS
ELVN
Relative Strength Index (RSI) 60.88 33.61
Support Level $26.68 $17.31
Resistance Level $32.31 $20.47
Average True Range (ATR) 1.13 1.39
MACD 0.45 -0.41
Stochastic Oscillator 70.20 6.66

Price Performance

Historical Comparison
PDFS
ELVN

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: